About 2,870 results

ALLMedicine™ Dry Skin Center

Research & Reviews  561 results

Biweekly administration of cetuximab in Japanese patients with recurrent or metastatic ...
International Journal of Clinical Oncology; Tanaka N, Enokida T et. al.

Aug 10th, 2022 - Cetuximab (Cmab) plays an important role in the treatment for recurrent or metastatic head and neck cancer (R/M HNC). To date, however, no safety data on biweekly administration of cetuximab at a dose of 500 mg/m2 (biweekly Cmab) for Japanese HNC ...

Dermatological Diseases in Palliative Care Patients in a University Hospital: A Prospec...
Journal of Palliative Care; Pala E, Tasar PT et. al.

Aug 9th, 2022 - Patients receiving palliative care are more prone to dermatological disease. The aim of our study was to determine the frequency of dermatological diseases and associated factors in patients receiving palliative care support. This prospective obse...

Dermatologic manifestations in patients with the Hermansky-Pudlak syndrome types 1 and 3.
Orphanet Journal of Rare Diseases; Santos Malave G, Izquierdo NJ et. al.

Jul 31st, 2022 - The Hermansky-Pudlak syndrome (HPS) is a genetically heterogeneous group of diseases characterized by oculocutaneous albinism, bleeding diathesis, and systemic complications. It is the most common genetic disorder in Puerto Rico. These patients ar...

Pediatric Atopic Dermatitis Clinical Presentation

Jul 27th, 2022 - History Diagnostic criteria for atopic dermatitis (AD) have been proposed by Hanifin and Rajka (1980) and largely adopted by the American Academy of Allergy, Asthma, and Immunology. [17] Appropriate cases must have at least 3 major characteristics...

Atopic Dermatitis

Jul 27th, 2022 - Practice Essentials Atopic dermatitis (AD) is a chronic, pruritic inflammatory skin condition (see image below) that typically affects the face (cheeks), neck, arms, and legs but usually spares the groin and axillary regions. AD usually starts in ...

see more →

Guidelines  1 results

Expert Consensus on the Management of Adverse Events from EGFR Tyrosine Kinase Inhibito...
Drugs Califano R, Tariq N et. al.

Jul 19th, 2015 - Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) such as gefitinib, erlotinib, and afatinib are standard-of-care for first-line treatment of EGFR-mutant advanced non-small cell lung cancer (NSCLC). These drugs have a prove...

see more →

Drugs  302 results see all →

Clinicaltrials.gov  64 results

A Study Osimertinib in Patients With Stage 4 Non-small Cell Lung Cancer With Uncommon EGFR Mutations

Jul 1st, 2022 - This is a research study to find out if a drug called, osimertinib, is safe and effective in treating advanced Non-Small Cell Lung Cancer (NSCLC) by targeting the treatment of epidermal growth factor receptor (EGFR) mutation exon 18 G719X, exon 20...

Seal, Stopping Eczema and Allergy Study

Jun 24th, 2022 - This is a randomized, controlled, parallel design, open-label phase 2 clinical study to compare the efficacy of the two proactive treatment arms versus the reactive arm, for the prevention of atopic dermatitis in children at high risk of food alle...

Effectiveness of Video Assisted Self Management Program on Chemotherapy Related Side Effects .

May 20th, 2022 - Effectiveness A measure of the extent to which a specific intervention, procedure, regimen, or service when deployed in the field of routine circumstances, does it intended to do for a specific population. (Wojtezak, 2002) In this study, effective...

Weekly Isotretinoin Therapy Study

May 9th, 2022 - In current Dermatology practice, options for moderate acne vulgaris remain limited. Moderate acne is clinically defined as acne that has not responded to at least three months of topical therapy and is not severe enough for initial treatment with ...

Evaluation of Skin Hydration in Adults With Dry Skin Using a Moisturizer With an Added Sterilized Probiotic

Apr 27th, 2022 - Double-blind placebo-controlled clinical trial to evaluate the effectiveness of a sterilized probiotic on skin health and hydration in adults with dry skin. The goal of the study is to determine if the addition of a skin-conditioning probiotic to ...

see more →

News  186 results

Dermatologists Skeptical of Calamine Lotion TikTok Trend

Aug 15th, 2022 - A growing bandwagon of TikTok influencers have been using and promoting calamine lotion as a makeup primer under foundation. Though this may seem to work as a base layer for some people, dermatologists have concerns about this trend, particularly ...

Itching at night
MDedge Family Medicine;

May 19th, 2022 - Microscopic evaluation of a dermoscopy-guided skin scraping revealed that this was a case of scabies. Classically, patients with scabies have many excoriated papules or plaques on their hands, genitals, and trunk with itching so intense that their.

An Update on JAK Inhibitors in Skin Disease
Alexandra Norden, BA, Aislyn Oulee, BS et. al.

Mar 3rd, 2022 - Atopic dermatitis (AD) is a chronic inflammatory skin disorder affecting 7% of adults and 13% of children in the United States. 1,2 Atopic dermatitis is characterized by pruritus, dry skin, and pain, all of which can negatively impact quality of li.

Dramatic Increase in Response With Combination for Relapsed/Resistant ITP

Jan 28th, 2022 - Patients with relapsed or corticosteroid-resistant immune thrombocytopenia (ITP) had a 33% higher response rate and 50% increase in sustained responses with all-trans retinoic acid (ATRA) plus low-dose rituximab (Rituxan), Chinese investigators re...

Adagrasib With or Without Cetuximab Produces Encouraging Clinical Activity in KRAS G12C–Mutant CRC

Jan 13th, 2022 - Adagrasib (MRTX849), both alone and in combination with cetuximab (Erbitux), demonstrated encouraging responses and disease control in heavily pretreated patients with KRAS G12C–mutated colorectal cancer (CRC), according to Jared Weiss, MD, who ad...

see more →

Patient Education  34 results see all →